AlphaYouCV
Insider buying
Christopher Viehbacher bought $1.5M of Braveheart Bio, Inc. (BRVE) stock
Christopher Viehbacher, Dir of Braveheart Bio, Inc. (BRVE), bought 83,333 shares of BRVE stock worth $1.5M, per an SEC Form 4 filed Aug 7, 2026.
It was an open-market purchase.
The trade happened on Aug 5, 2026, 2 days before it was made public.
- Traded
- Aug 5, 2026
- Disclosed
- Aug 7, 2026
- Filing delay
- 2 days
- Role
- Dir
- Source
- SEC Form 4
More BRVE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.